Related references
Note: Only part of the references are listed.The Clinical Spectrum of PTEN Mutations
Lamis Yehia et al.
ANNUAL REVIEW OF MEDICINE, VOL 71, 2020 (2020)
PTEN in Hereditary and Sporadic Cancer
Joanne Ngeow et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2020)
PTEN Nuclear Functions
Jason Ho et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2020)
Suppression of Nonsense Mutations by New Emerging Technologies
Pedro Morais et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Mechanisms of PTEN loss in cancer: It's all about diversity
Virginia Alvarez-Garcia et al.
SEMINARS IN CANCER BIOLOGY (2019)
Nonsense mutation-dependent reinitiation of translation in mammalian cells
Sarit Cohen et al.
NUCLEIC ACIDS RESEARCH (2019)
Strategies against Nonsense: Oxadiazoles as Translational Readthrough-Inducing Drugs (TRIDs)
Ambra Campofelice et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Precise Immunodetection of PTEN Protein in Human Neoplasia
Rafael Pulido et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2019)
COSMIC: the Catalogue Of Somatic Mutations In Cancer
John G. Tate et al.
NUCLEIC ACIDS RESEARCH (2019)
A breakthrough in readthrough? Could geneticin lead the way to effective treatment for cystinosis nonsense mutations?
Julian Midgley
PEDIATRIC NEPHROLOGY (2019)
Precise definition of PTEN C-terminal epitopes and its implications in clinical oncology
Janire Mingo et al.
NPJ PRECISION ONCOLOGY (2019)
A Saturation Mutagenesis Approach to Understanding PTEN Lipid Phosphatase Activity and Genotype-Phenotype Relationships
Taylor L. Mighell et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
A pathogenic role for germline PTEN variants which accumulate into the nucleus
Janire Mingo et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2018)
Advances in therapeutic use of a drug-stimulated translational readthrough of premature termination codons
Maciej Dabrowski et al.
MOLECULAR MEDICINE (2018)
The functions and regulation of the PTEN tumour suppressor: new modes and prospects
Yu-Ru Lee et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies
Peter D. Stenson et al.
HUMAN GENETICS (2017)
Identification of the amino acids inserted during suppression of CFTR nonsense mutations and determination of their functional consequences
Xiaojiao Xue et al.
HUMAN MOLECULAR GENETICS (2017)
Characterization of new-generation aminoglycoside promoting premature termination codon readthrough in cancer cells
Laure Bidou et al.
RNA BIOLOGY (2017)
The nucleoside analog clitocine is a potent and efficacious readthrough agent
Westley J. Friesen et al.
RNA (2017)
High-Throughput Screening for Readthrough Modulators of CFTR PTC Mutations
Feng Liang et al.
SLAS TECHNOLOGY (2017)
Therapeutic Suppression of Nonsense Mutation: An Emerging Target in Multiple Diseases and Thrombotic Disorders
Md. Asiful Islam et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Targeting Nonsense Mutations in Diseases with Translational Read-Through-Inducing Drugs (TRIDs)
Kerstin Nagel-Wolfrum et al.
BIODRUGS (2016)
Novel small molecules potentiate premature termination codon readthrough by aminoglycosides
Alireza Baradaran-Heravi et al.
NUCLEIC ACIDS RESEARCH (2016)
One-Tube-Only Standardized Site-Directed Mutagenesis: An Alternative Approach to Generate Amino Acid Substitution Collections
Janire Mingo et al.
PLOS ONE (2016)
Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression
Bijoyita Roy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Design of Novel Aminoglycoside Derivatives with Enhanced Suppression of Diseases-Causing Nonsense Mutations
Narayana Murthy Sabbavarapu et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
Yeast-based methods to assess PTEN phosphoinositide phosphatase activity in vivo
Isabel Rodriguez-Escudero et al.
METHODS (2015)
PTEN-PDZ domain interactions: Binding of PTEN to PDZ domains of PTPN13
Natalia S. Sotelo et al.
METHODS (2015)
PTEN: A yin-yang master regulator protein in health and disease
Rafael Pulido
METHODS (2015)
Translational readthrough potential of natural termination codons in eucaryotes - The impact of RNA sequence
Maciej Dabrowski et al.
RNA BIOLOGY (2015)
Genome-wide mutational spectra analysis reveals significant cancer-specific heterogeneity
Hua Tan et al.
SCIENTIFIC REPORTS (2015)
PTEN: multiple functions in human malignant tumors
Michele Milella et al.
FRONTIERS IN ONCOLOGY (2015)
Functionally distinct groups of inherited PTEN mutations in autism and tumour syndromes
Laura Spinelli et al.
JOURNAL OF MEDICAL GENETICS (2015)
PTEN
Carolyn A. Worby et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 83 (2014)
Therapeutics Based on Stop Codon Readthrough
Kim M. Keeling et al.
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 15 (2014)
Cancer-Associated PTEN Mutants Act in a Dominant-Negative Manner to Suppress PTEN Protein Function
Antonella Papa et al.
CELL (2014)
Ataluren as an Agent for Therapeutic Nonsense Suppression
Stuart W. Peltz et al.
ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)
High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome
Virginie Bubien et al.
JOURNAL OF MEDICAL GENETICS (2013)
The functions and regulation of the PTEN tumour suppressor
Min Sup Song et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Statistical Analysis of Readthrough Levels for Nonsense Mutations in Mammalian Cells Reveals a Major Determinant of Response to Gentamicin
Celia Floquet et al.
PLOS GENETICS (2012)
A Clinical Scoring System for Selection of Patients for PTEN Mutation Testing Is Proposed on the Basis of a Prospective Study of 3042 Probands
Min-Han Tan et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes
Isabel Rodriguez-Escudero et al.
HUMAN MOLECULAR GENETICS (2011)
Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome clinical features
Robert Pilarski et al.
JOURNAL OF MEDICAL GENETICS (2011)
Rescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides
Celia Floquet et al.
NUCLEIC ACIDS RESEARCH (2011)
Readthrough of Premature Termination Codons in the Adenomatous Polyposis Coli Gene Restores Its Biological Activity in Human Cancer Cells
Celia Floquet et al.
PLOS ONE (2011)
Non-genomic loss of PTEN function in cancer: not in my genes
Nick R. Leslie et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Restoration of APC gene function in colorectal cancer cells by aminoglycoside- and macrolide-induced read-through of premature termination codons
Alona Zilberberg et al.
GUT (2010)
Subtle variations in Pten dose determine cancer susceptibility
Andrea Alimonti et al.
NATURE GENETICS (2010)
A meta-analysis of nonsense mutations causing human genetic disease
Matthew Mort et al.
HUMAN MUTATION (2008)
Assessment of PTEN tumor suppressor activity in nonmammalian models:: the year of the yeast
V. J. Cid et al.
ONCOGENE (2008)
Introducing sense into nonsense in treatments of human genetic diseases
Liat Linde et al.
TRENDS IN GENETICS (2008)
In vivo functional analysis of the counterbalance of hyperactive phosphatidylinositol 3-kinase p110 catalytic oncoproteins by the tumor suppressor PTEN
Amparo Andres-Pons et al.
CANCER RESEARCH (2007)
Aminoglycoside antibiotics: old drugs and new therapeutic approaches
T. Hermann
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Nuclear localization of PTEN by a ran-dependent mechanism enhances apoptosis:: Involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs
Anabel Gil et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast
I Rodríguez-Escudero et al.
BIOCHEMICAL JOURNAL (2005)
Premature stop codons involved in muscular dystrophies show a broad spectrum of readthrough efficiencies in response to gentamicin treatment
L Bidou et al.
GENE THERAPY (2004)
The major 5 ' determinant in stop codon read-through involves two adjacent adenines
S Tork et al.
NUCLEIC ACIDS RESEARCH (2004)
Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system
KM Keeling et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2002)
Phosphorylation of the PTEN tail regulates protein stability and function
F Vazquez et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system
M Manuvakhova et al.
RNA (2000)
Share Paper
